Crowdonomics
All companies
Terra Biotics, Inc. logo

Terra Biotics, Inc.

Operating

Parvus Capital Corp dba Terra Biotics

Healthcare · Frisco, TX · Founded 2019

Organic Plant Nutrients

Post-money valuation ⓘ
$8.3M
As of Sep 2021 · from Reg CF Offering (2020) · pre-money + amount raised, not a traded price
Total raised
$291,785
Crowd $165K · Private $127K · 2 rounds since 2019
Latest share price
$10.00
Reg CF · Common Stock · Dec 2020 offering price

Financials

FY2018–FY2024 (no data for FY2021) · from SEC filings · hover any figure for its source
$0
2018
$105K
−$14K
2019
$229K
−$58K
2020
2021no data
$314K
−$75K
2022
$541K
$23K
2023
$259K
−$35K
2024
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2018
FY2019 unaudited
FY2020 unaudited
FY2022 unaudited
FY2023 unaudited
FY2024 unaudited
Income statement
Revenue
$0
$104,817
$228,897
$313,782
$541,354
$258,829
Cost of goods sold
$0
$52,309
$132,285
$167,855
$307,714
$136,941
Gross margin
—
50%
42%
47%
43%
47%
Net income
$0
-$14,143
-$58,354
-$74,530
$23,413
-$34,595
Taxes paid
$0
$0
$0
$0
$161
$689
Balance sheet
Cash
$0
$19,288
$20,192
$7,607
$8,236
$409
Accounts receivable
$0
$16,829
$6,439
$53,333
$41,943
$60,333
Total assets
$0
$513,249
$432,986
$512,039
$522,959
$487,348
Short-term debt
$0
$52,247
$15,437
$13,769
$9,000
$9,020
Long-term debt
$0
$348,000
$362,900
$359,075
$351,352
$350,316
Total liabilities
$0
$400,247
$378,337
$372,844
$360,352
$359,336
Other
Headcount
—
3
3
—
3
3

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Pre-money — the valuation set before each round’s money came in
$8.1M
pre-money
Reg CF · Common · Dec 2020

Blue bars are the pre-money valuation the company stated for a priced round.

Share price over rounds

$10.0051$5.0026$10.00
May 2019Dec 2020
Round offering price or verified disclosed saleDisclosed sale, unverified or year-only

Disclosed sales come from the issuer's own filings (prior-offering lines, audited-statement notes) and are amount ÷ securities sold. A down round is a firm point more than 25 % below the previous firm point of the same share class on a comparable basis; the comparison ignores unverified and year-only lines.

Fundraising history

Raised $164.6K / $250KInvestors 287Post-money $8.3M

Team

2 people
Jared ElliottFounder
President, Director, Treasurer, and Secretary

Jared has over 25 years leadership experience in strategy, marketing, building profitable businesses and growth. He earned an MBA from top tier school. President of Bestolife - Oversaw all functions and drove strategic direction of the company. Launched new products, implemented pricing and profitability tools, pushed for improved sourcing costs, improved gross margin and overall profitability. Director roles in Celanese for $1B businesses developing new products and building new sites around the world. Director of Strategy & Marketing for $2.6B business in DuPont with 88 business unit leaders and strategic marketing team members reporting to him. Led business unit in DuPont, developing and implementing a business plan to grow revenue significantly over 18 months. Launched hundreds of millions dollars annual sales worth of new products in multiple industries. Outside of work, Jared is the proud father of four great children, loves exploring foods from around the world and traveling.

Mark Aguilera
Operations Manager

Mark has over 28 years leadership experience in operations, customer relations, shipping and management roles. He has been working with the Terra Biotics team for over a decade. Mark is the key person who gets things done while placing customer needs at the forefront. He leads our manufacturing, packaging and shipping teams and also has significant customer and certifier interaction.

Names and titles as disclosed on SEC Form C, StartEngine. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Not requiredFewer than 300 holders of record

Filed 3 of 6 annual reports (FY2020–FY2025)

287 investors
holder-count proxy

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

  • Form C-ARApr 30, 20250001665160-25-000898
    EDGAR
  • Form C-ARApr 23, 20240001665160-24-000447
    EDGAR
  • Form C-UAug 31, 20210001665160-21-001567
    EDGAR
  • Form C/AJul 28, 20210001665160-21-001350
    EDGAR
  • Form C-AR/AJul 27, 20210001665160-21-001339
    EDGAR
  • Form C-ARApr 27, 20210001665160-21-000560
    EDGAR
  • Form C/AApr 21, 20210001665160-21-000503
    EDGAR
  • Form C/AMar 3, 20210001665160-21-000267
    EDGAR
Source: ManualCIK 0001835501TXShare price $10.00

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.